Research Article
Prognostic Evaluation of Vimentin Expression in Correlation with Ki67 and CD44 in Surgically Resected Pancreatic Ductal Adenocarcinoma
Table 3
Expression rates of the studied markers.
| Marker | n (%) |
| CD44 | Low | 12 (22.6%) | Moderate | 8 (15.1%) | High | 33 (62.3%) | Ki67 | Nil | 1 (1.9%) | Low | 23 (43.4%) | High | 29 (54.7%) | Vimentin | Negative | 21 (39.6%) | Positive | 32 (60.4%) |
|
|